HDSA 2026: New oral therapy headed for pivotal Huntington’s trial
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A new oral therapy is reportedly headed for a pivotal trial in the treatment of Huntington's disease. Other potential treatments, including gene therapy and stem cell therapy, may also be moving forward, with some outlets mentioning specific trials and grants. The status of various treatments and trials is not entirely clear, with different outlets reporting on different developments in Huntington's disease research.
Full coverage
12345678